AstraZeneca results reassure on long-term growth as three brokers raise price targets
AstraZeneca PLC (LSE:AZN, NYSE:AZN), the Anglo-Swedish drugmaker, saw three brokers raise their price targets after its third-quarter results, with analysts...
What's Your Reaction?









